Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received-Reference-Cited by-同舟云学术

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

Published:2016-08-20 Issue:24 Volume:34 Page:2925-2934
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Schnipper Lowell E.¹,Davidson Nancy E.¹,Wollins Dana S.¹,Blayney Douglas W.¹,Dicker Adam P.¹,Ganz Patricia A.¹,Hoverman J. Russell¹,Langdon Robert¹,Lyman Gary H.¹,Meropol Neal J.¹,Mulvey Therese¹,Newcomer Lee¹,Peppercorn Jeffrey¹,Polite Blase¹,Raghavan Derek¹,Rossi Gregory¹,Saltz Leonard¹,Schrag Deborah¹,Smith Thomas J.¹,Yu Peter P.¹,Hudis Clifford A.¹,Vose Julie M.¹,Schilsky Richard L.¹

Affiliation:

1. Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Harvard Medical School; Therese Mulvey and Jeffrey Peppercorn, Massachusetts General Hospital; Deborah Schrag, Dana-Farber Cancer Institute, Boston, MA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh; Adam P. Dicker, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA; Dana S. Wollins and Richard L. Schilsky, American Society of Clinical...

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.68.2518

Reference8 articles.

1. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

2. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

3. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

4. Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

Cited by 544 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolving value assessment of cancer therapies: Results from a modified Delphi study;Health Policy OPEN;2024-12

2. Narrative review of value frameworks in urothelial carcinoma and positioning of enfortumab vedotin;Journal of Medical Economics;2024-09-11

3. Documenting the Full Value of Vaccination: A Systematic Review of Value Frameworks;Value in Health;2024-09

4. Management of Locally Advanced Rectal Cancer: ASCO Guideline;Journal of Clinical Oncology;2024-08-08

5. Time to Update—Requesting Inclusive Submission Categories for Oncology Research;JCO Global Oncology;2024-08